Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure

Ferlay J, Bray F, Pisani P, Parkin DM, Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon: IARC Press. IARC Cancer Base No. 5; 2001. ENCR. European Network of Cancer Registries. European Cancer Incidence and Mortality (EUROCIM). Lyon: Internation Agency for Research on Cancer; 1997. Falk, 1989, Effect of smoking and alcohol consumption on laryngeal cancer risk in coastal Texas, Cancer Res, 49, 4024 Cann, 1985, Epidemiology of squamous cell cancer of the head and neck, Otolaryngol Clin. North. Am., 18, 367, 10.1016/S0030-6665(20)31838-7 Sherr, 1996, Cancer cell cycles, Science, 274, 1672, 10.1126/science.274.5293.1672 Hunter, 1994, Cyclin and cancer II: cyclinD and CDK inhibitors come of age, Cell, 79, 573, 10.1016/0092-8674(94)90543-6 Jiang, 1992, Amplification and expression of human cyclin D gene in esophageal cancer, Cancer Res, 52, 2980 Arber, 1996, Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis, Gastroenterology, 110, 669, 10.1053/gast.1996.v110.pm8608874 Bukley, 1993, Expression and amplification of cyclin genes in human breast cancer, Oncogene, 8, 2127 Akervall, 1997, Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognosis value of chromosomal abnormalities and cyclin D1 overexpression, Cancer, 79, 380, 10.1002/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.0.CO;2-W Betticher, 1996, Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer, Br J. Cancer, 73, 294, 10.1038/bjc.1996.52 Betticher, 1995, Alternate splicing produces a novel cyclin D1 transcript, Oncogene, 11, 1005 Sawa, 1998, Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner, Oncogene, 16, 1701, 10.1038/sj.onc.1201691 Kong, 2000, Effects of cyclin D1 polymorphism on age onset of hereditary nonpolyposis colorectal cancer, Cancer Res, 60, 249 Matthias, 1998, Polymnorphisms within the Cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck, Clin Cancer Res, 4, 2411 Gramlich, 1994, Differential Polymerase chain reaction assay of cyclin D1 gene amplification in esophageal carcinoma, Diagnostic Mol. Pathol., 3, 255, 10.1097/00019606-199412000-00007 Schneeberger, 1998, A differential PCR system for the determination of CCND1 (Cyclin D1) gene amplification in head and neck squamous cell carcinomas, Oral Oncol, 34, 257, 10.1016/S1368-8375(98)80004-3 Nogueira, 1998, Inactivation of p53 and amplification of cyclin D1 correlate with outcome in head and neck cancer, Laryngoscope, 108, 345, 10.1097/00005537-199803000-00007 Berenson, 1989, Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas, Oncogene, 4, 1111 Somers, 1990, Amplification of the int-2 gene in human head and neck squamous cell carcinomas, Oncogene, 5, 915 Volling, 1993, Coamplification of the hst-1 and bcl-1 oncogenes in advanced squamous cell carcinomas of the head and neck, Eur. J. Cancer, 29A, 383, 10.1016/0959-8049(93)90392-S Callender, 1994, PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma, Cancer, 74, 152, 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K Jares, 1994, PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in laryngeal carcinomas, Cancer Res, 54, 4813 Bellacosa, 1996, Cyclin D1 amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications, Clin. Cancer Res, 2, 175 Davidson, 1996, Cyclin D1 abnormalities and tobacco exposure in head and neck squamous cell carcinoma, Head Neck, 18, 512, 10.1002/(SICI)1097-0347(199611/12)18:6<512::AID-HED5>3.0.CO;2-5 Worsley, 1996, Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression, J. Clin. Pathol. Mol. Pathol., 49, M46, 10.1136/mp.49.1.M46 Simpson, 2001, Cyclin D1 (CCND1) genotype is associated with tumor grade in sporadic pituitary adenomas, Carcinogenesis, 22, 1801, 10.1093/carcin/22.11.1801 Zhang, 2002, Polymorphisms in cyclin D1 gene and hepatocellular carcinoma, Mol. Carcinog., 33, 125, 10.1002/mc.10028 Wang, 2002, Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer, Carcinogenesis, 23, 257, 10.1093/carcin/23.2.257 McKay, 2000, Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative, Int J. Cancer, 88, 77, 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O Zheng, 2001, Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case control study, Carcinogenesis, 22, 1195, 10.1093/carcin/22.8.1195 Michaels L, Larynx. In: McGee J O’D, Isaacson PG, Wright NA, editors. Oxford Text Book of Pathology. Oxford: Oxford University Press; 1992. p. 1124–30. Tuyns, 1988, Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France), Int. J. Cancer, 41, 483, 10.1002/ijc.2910410403 Freier, 2003, Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma, Cancer Res, 63, 1179 Huang, 2002, Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumors sites: construction of oncogenic trees for tumor progression. Genes, Chromosomes and Cancer, 34, 224, 10.1002/gcc.10062